Facebook Twitter LinkedIn Google Plus RSS

Bard board approves stock buyback

By ,

Medical technology company C.R. Bard Inc. announced Wednesday that its Board of Directors had approved the repurchase of up to $500 million in common stock.

This amount increases the approximately $30 million remaining from a previous repurchase authorization in January.

C.R. Bard has its headquarters in Murray Hill.


New 76ers practice hub, offices in Camden among nearly $190M in tax breaks approved by EDA

Pinnacle unveils plans for new $35M hotel project in downtown Montclair

NJBIZ General Counsel winners: Seven top lawyers bring home big awards

Also Popular on NJBIZ

Eric Strauss

Eric Strauss

Eric Strauss is the digital content editor for NJBIZ. He has been a reporter and editor for newspapers in New Jersey and Pennsylvania, as well as for a number of websites. You can contact him at erics@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!